Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $10.96 billion. The enterprise value is $11.49 billion.
| Market Cap | 10.96B |
| Enterprise Value | 11.49B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 69.26 million shares outstanding. The number of shares has decreased by -4.16% in one year.
| Current Share Class | 69.26M |
| Shares Outstanding | 69.26M |
| Shares Change (YoY) | -4.16% |
| Shares Change (QoQ) | -0.66% |
| Owned by Insiders (%) | 0.31% |
| Owned by Institutions (%) | 104.07% |
| Float | 68.99M |
Valuation Ratios
The trailing PE ratio is 36.89 and the forward PE ratio is 23.65. Insulet's PEG ratio is 1.03.
| PE Ratio | 36.89 |
| Forward PE | 23.65 |
| PS Ratio | 3.78 |
| Forward PS | 3.18 |
| PB Ratio | 8.41 |
| P/TBV Ratio | 9.65 |
| P/FCF Ratio | 26.37 |
| P/OCF Ratio | 17.70 |
| PEG Ratio | 1.03 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.09, with an EV/FCF ratio of 27.65.
| EV / Earnings | 37.96 |
| EV / Sales | 3.96 |
| EV / EBITDA | 19.09 |
| EV / EBIT | 22.67 |
| EV / FCF | 27.65 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.78.
| Current Ratio | 2.49 |
| Quick Ratio | 1.49 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 1.65 |
| Debt / FCF | 2.44 |
| Interest Coverage | 7.81 |
Financial Efficiency
Return on equity (ROE) is 23.00% and return on invested capital (ROIC) is 20.87%.
| Return on Equity (ROE) | 23.00% |
| Return on Assets (ROA) | 9.75% |
| Return on Invested Capital (ROIC) | 20.87% |
| Return on Capital Employed (ROCE) | 22.05% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | $537,185 |
| Profits Per Employee | $56,074 |
| Employee Count | 5,400 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, Insulet has paid $101.60 million in taxes.
| Income Tax | 101.60M |
| Effective Tax Rate | 25.12% |
Stock Price Statistics
The stock price has decreased by -48.32% in the last 52 weeks. The beta is 1.12, so Insulet's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -48.32% |
| 50-Day Moving Average | 160.01 |
| 200-Day Moving Average | 251.43 |
| Relative Strength Index (RSI) | 55.64 |
| Average Volume (20 Days) | 1,637,374 |
Short Selling Information
The latest short interest is 4.90 million, so 7.08% of the outstanding shares have been sold short.
| Short Interest | 4.90M |
| Short Previous Month | 4.23M |
| Short % of Shares Out | 7.08% |
| Short % of Float | 7.11% |
| Short Ratio (days to cover) | 2.20 |
Income Statement
In the last 12 months, Insulet had revenue of $2.90 billion and earned $302.80 million in profits. Earnings per share was $4.29.
| Revenue | 2.90B |
| Gross Profit | 2.06B |
| Operating Income | 507.10M |
| Pretax Income | 404.40M |
| Net Income | 302.80M |
| EBITDA | 602.00M |
| EBIT | 507.10M |
| Earnings Per Share (EPS) | $4.29 |
Balance Sheet
The company has $480.40 million in cash and $1.01 billion in debt, giving a net cash position of -$533.60 million or -$7.70 per share.
| Cash & Cash Equivalents | 480.40M |
| Total Debt | 1.01B |
| Net Cash | -533.60M |
| Net Cash Per Share | -$7.70 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 18.81 |
| Working Capital | 1.02B |
Cash Flow
In the last 12 months, operating cash flow was $619.30 million and capital expenditures -$203.60 million, giving a free cash flow of $415.70 million.
| Operating Cash Flow | 619.30M |
| Capital Expenditures | -203.60M |
| Depreciation & Amortization | 94.90M |
| Net Borrowing | -986.10M |
| Free Cash Flow | 415.70M |
| FCF Per Share | $6.00 |
Margins
Gross margin is 71.01%, with operating and profit margins of 17.48% and 10.44%.
| Gross Margin | 71.01% |
| Operating Margin | 17.48% |
| Pretax Margin | 13.94% |
| Profit Margin | 10.44% |
| EBITDA Margin | 20.75% |
| EBIT Margin | 17.48% |
| FCF Margin | 14.33% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.15% |
| Shareholder Yield | n/a |
| Earnings Yield | 2.76% |
| FCF Yield | 3.79% |
Analyst Forecast
The average price target for Insulet is $240.25, which is 53.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $240.25 |
| Price Target Difference | 53.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 19.73% |
| EPS Growth Forecast (3Y) | 26.89% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 9.44 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.44 |
| Piotroski F-Score | 7 |